Research is completely lacking when it comes to information about women’s hormonal health. Today’s guest is working to compile data and help women find the care they need. This week on Found, we’re talking to Sylvia Kang, the CEO and co-founder of Mira, a women’s health company that is providing home hormonal testing. They discuss the challenges on fundraising for women’s health startups, the importance of research to drive change and access in healthcare, and how Mira forged a new path by becoming FDA approved.
00:00 – Introduction and Overview of Women’s Hormonal Health
01:45 – The Lack of Hormonal Health Data and Fertility Challenges
05:11 – The Inspiration Behind Starting Mira
07:30 – Early Feedback from Doctors and Investors
10:58 – The Evolution of the Women’s Health Market
13:25 – Overcoming the Lack of Scientific Research and Data Collection
16:51 – Impact of COVID-19 on Mira’s Growth
18:42 – Mira as a Cost-Effective Solution to Fertility Issues
21:29 – Mira’s Expansion Beyond Fertility and into IVF
25:02 – Utilizing AI to Personalize Hormonal Health Tracking
28:35 – Sylvia’s Journey from Corporate to Entrepreneurship
32:15 – Building a Female-Driven Company Culture at Mira
34:49 – The Future of Women’s Health and Expanding Mira’s Impact
Found posts every Tuesday. Subscribe on Apple () , Spotify () or wherever you listen to podcasts () to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity () .
Connect with us:
• On Twitter ()
• On Instagram ()
• Via email: found@techcrunch.com
